Financhill
Back

Design Therapeutics Quote, Financials, Valuation and Earnings

Design Therapeutics Price Quote

$6.08
-1.42 (-18.93%)
(Updated: November 14, 2024 at 5:55 PM ET)

Design Therapeutics Key Stats

Buy
56
Design Therapeutics (DSGN) is a Buy

Day range:
$6.95 - $7.77
52-week range:
$2.13 - $6.95
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.5%

Volume:
397.5K
Avg. volume:
153.8K
1-year change:
265.85%
Market cap:
$391.3M
Revenue:
$0
EPS:
$-0.9

How Much Does Design Therapeutics Make?

Data Unavailable

Is Design Therapeutics Growing As A Company?

Data Unavailable

Design Therapeutics Stock Price Performance

What Is Design Therapeutics 52-Week High & Low?

Design Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Design Therapeutics?

Is Design Therapeutics Cash Flow Positive?

  • What Is DSGN Cash Flow From Operations?
    Cash flow from operations (TTM) is -$51M
  • What Is Design Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $763K
  • What Is Design Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $68.8M

Design Therapeutics Return On Invested Capital

Data Unavailable

Design Therapeutics Earnings Date & Stock Price

Design Therapeutics Competitors

Design Therapeutics Dividend Yield

Design Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 5.48%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 7.00
Downside from Last Price: -6.67%

Major Shareholders

  • How many DSGN shares are owned by institutional investors?
    41.6M DSGN shares are owned by institutional investors
  • How many DSGN shares are owned by insiders?
    1.2M DSGN shares are owned by insiders